Man Group’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.11M Buy
78,021
+21,333
+38% +$717K ﹤0.01% 1555
2025
Q4
$2.43M Buy
56,688
+33,853
+148% +$1.28M ﹤0.01% 1386
2025
Q3
$647K Buy
22,835
+11,063
+94% +$331K ﹤0.01% 1791
2025
Q2
$220K Buy
11,772
+1,501
+15% +$28.5K ﹤0.01% 2047
2025
Q1
$185K Sell
10,271
-7,885
-43% -$160K ﹤0.01% 2040
2024
Q4
$305K Sell
18,156
-7,442
-29% -$143K ﹤0.01% 1782
2024
Q3
$414K Buy
25,598
+149
+0.6% +$1.75K ﹤0.01% 1700
2024
Q2
$209K Buy
25,449
+13,349
+110% +$140K ﹤0.01% 1881
2024
Q1
$179K Buy
+12,100
New +$163K ﹤0.01% 2023
2023
Q1
Sell
-13,011
Closed -$207K 1813
2022
Q4
$195K Buy
13,011
+10,465
+411% +$95.9K ﹤0.01% 1776
2022
Q3
$30K Buy
+2,546
New +$34.4K ﹤0.01% 1919
2019
Q4
Sell
-1,100
Closed -$21K 1892
2019
Q3
$21K Buy
+1,100
New +$22.7K ﹤0.01% 1762
2018
Q3
Sell
-4,400
Closed -$125K 2204
2018
Q2
$125K Buy
+4,400
New +$157K ﹤0.01% 2062

Other funds holding RIGL